Second-line treatment of EGFR T790M-negative non-small cell lung cancer patients

por Liao, Bin-Chi, Griesing, Sebastian, Yang, James Chih-Hsin
Publicado 2019

First-line afatinib for the treatment of EGFR mutation-positive non-small-cell lung cancer in the ‘real-world’ clinical setting

por Park, Keunchil, Wan-Teck Lim, Darren, Okamoto, Isamu, Yang, James Chih-Hsin
Publicado 2019

Update on recent preclinical and clinical studies of T790M mutant-specific irreversible epidermal growth factor receptor tyrosine kinase inhibitors

por Liao, Bin-Chi, Lin, Chia-Chi, Lee, Jih-Hsiang, Yang, James Chih-Hsin
Publicado 2016

The Inhibition of Wnt Restrain KRAS(G12V)-Driven Metastasis in Non-Small-Cell Lung Cancer

por Hung, Pei-Shan, Huang, Ming-Hung, Kuo, Yuan-Yeh, Yang, James Chih-Hsin
Publicado 2020

The effectiveness of afatinib in patients with lung adenocarcinoma harboring complex epidermal growth factor receptor mutation

por Wu, Shang-Gin, Yu, Chong-Jen, Yang, James Chih-Hsin, Shih, Jin-Yuan
Publicado 2020

Adjusted Indirect Comparison Using Propensity Score Matching of Osimertinib to Platinum-Based Doublet Chemotherapy in Patients with EGFRm T790M NSCLC Who Have Progressed after EGFR...

por Mann, Helen, Andersohn, Frank, Bodnar, Carolyn, Mitsudomi, Tetsuya, Mok, Tony S. K., Yang, James Chih-Hsin, Hoyle, Christopher
Publicado 2017

Circulating Exosomal Integrin β3 Is Associated with Intracranial Failure and Survival in Lung Cancer Patients Receiving Cranial Irradiation for Brain Metastases: A Prospective Obse...

por Chen, Guann-Yiing, Cheng, Jason Chia-Hsien, Chen, Ya-Fang, Yang, James Chih-Hsin, Hsu, Feng-Ming
Publicado 2021

Maximizing Benefits from Maintenance Pemetrexed with Stereotactic Ablative Radiotherapy in Oligoprogressive Non-Squamous Non-Small Cell Lung Cancer

por Lu, Shao-Lun, Hsu, Feng-Ming, Chen, Kuan-Yu, Ho, Chao-Chi, Yang, James Chih-Hsin, Cheng, Jason Chia-Hsien
Publicado 2016

Enhancing Anticancer Effect of Gefitinib across the Blood–Brain Barrier Model Using Liposomes Modified with One α-Helical Cell-Penetrating Peptide or Glutathione and Tween 80

por Lin, Kuan-Hung, Hong, Shu-Ting, Wang, Hsiang-Tsui, Lo, Yu-Li, Lin, Anya Maan-Yuh, Yang, James Chih-Hsin
Publicado 2016

INSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancer

por Wu, Yi-Long, Park, Keunchil, Soo, Ross A, Sun, Yan, Tyroller, Karin, Wages, David, Ely, Guy, Yang, James Chih-Hsin, Mok, Tony
Publicado 2011

Improving the anticancer effect of afatinib and microRNA by using lipid polymeric nanoparticles conjugated with dual pH-responsive and targeting peptides

por Hong, Shu-Ting, Lin, Huaching, Wang, Chen-Shen, Chang, Chih-Hsien, Lin, Anya Maan-Yuh, Yang, James Chih-Hsin, Lo, Yu-Li
Publicado 2019

Chloroquine Enhances Gefitinib Cytotoxicity in Gefitinib-Resistant Nonsmall Cell Lung Cancer Cells

por Tang, Mei-Chuan, Wu, Mei-Yi, Hwang, Ming-Hung, Chang, Ya-Ting, Huang, Hui-Ju, Lin, Anya Maan-Yuh, Yang, James Chih-Hsin
Publicado 2015

Phase I Study of the Focal Adhesion Kinase Inhibitor BI 853520 in Japanese and Taiwanese Patients with Advanced or Metastatic Solid Tumors

por Doi, Toshihiko, Yang, James Chih-Hsin, Shitara, Kohei, Naito, Yoichi, Cheng, Ann-Lii, Sarashina, Akiko, Pronk, Linda C., Takeuchi, Yoshito, Lin, Chia-Chi
Publicado 2019

Afatinib for the Treatment of Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: An Updated Database of 1023 Cases Brief Report

por Yang, James Chih-Hsin, Schuler, Martin, Popat, Sanjay, Miura, Satoru, Park, Keunchil, Passaro, Antonio, De Marinis, Filippo, Solca, Flavio, Märten, Angela, Kim, Edward S.
Publicado 2022

Efficacy and Safety of S-1 Compared With Docetaxel in Elderly Patients With Advanced NSCLC Previously Treated With Platinum-Based Chemotherapy: A Subgroup Analysis of the EAST-LC T...

por Yang, James Chih-Hsin, Mok, Tony S.K., Lu, Shun, Nakagawa, Kazuhiko, Yamamoto, Nobuyuki, Shi, Yuan-Kai, Zhang, Li, Soo, Ross A., Morita, Satoshi, Tamura, Tomohide
Publicado 2021

The Response, Outcome and Toxicity of Aggressive Palliative Thoracic Radiotherapy for Metastatic Non-Small Cell Lung Cancer Patients with Controlled Extrathoracic Diseases

por Chiang, Yun, Yang, James Chih-Hsin, Hsu, Feng-Ming, Chen, Yu-Hsuan, Shih, Jin-Yuan, Lin, Zhong-Zhe, Lan, Keng-Hsueh, Cheng, Ann-Lii, Kuo, Sung-Hsin
Publicado 2015

Osimertinib in Patients with T790M-Positive Advanced Non-small Cell Lung Cancer: Korean Subgroup Analysis from Phase II Studies

por Ahn, Myung-Ju, Han, Ji-Youn, Kim, Dong-Wan, Cho, Byoung Chul, Kang, Jin-Hyoung, Kim, Sang-We, Yang, James Chih-Hsin, Mitsudomi, Tetsuya, Lee, Jong Seok
Publicado 2020

IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer

por Liu, Yi-Nan, Chang, Tzu-Hua, Tsai, Meng-Feng, Wu, Shang-Gin, Tsai, Tzu-Hsiu, Chen, Hsuan-Yu, Yu, Sung-Liang, Yang, James Chih-Hsin, Shih, Jin-Yuan
Publicado 2015

The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients

por Wu, Shang-Gin, Liu, Yi-Nan, Tsai, Meng-Feng, Chang, Yih-Leong, Yu, Chong-Jen, Yang, Pan-Chyr, Yang, James Chih-Hsin, Wen, Yueh-Feng, Shih, Jin-Yuan
Publicado 2016

Cytotoxic Chemotherapy as First-Line Therapy for Advanced Non-Small-Cell Lung Cancer in Taiwan: Daily Practice

por Liang, Yi-Hsin, Shao, Yu-Yun, Liao, Bin-Chi, Lee, Ho-Sheng, Yang, James Chih-Hsin, Chen, Ho-Min, Chiang, Chun-Ju, Cheng, Ann-Lii, Lai, Mei-Shu
Publicado 2016